Harrow, Inc.

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Harrow, Inc. and other ETFs, options, and stocks.

About HROW

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development.

CEO

Mark L. Baum

CEOMark L. Baum

Employees

382

Employees382

Headquarters

Nashville, Tennessee

HeadquartersNashville, Tennessee

Founded

2006

Founded2006

Employees

382

Employees382

HROW Key Statistics

Market cap

1.14B

Market cap1.14B

Price-Earnings ratio

-51.10

Price-Earnings ratio-51.10

Dividend yield

—

Dividend yield—

Average volume

300.77K

Average volume300.77K

High today

$32.17

High today$32.17

Low today

$30.97

Low today$30.97

Open price

$31.57

Open price$31.57

Volume

316.58K

Volume316.58K

52 Week high

$59.23

52 Week high$59.23

52 Week low

$20.85

52 Week low$20.85

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own HROW. This list is generated using Robinhood data, and it’s not a recommendation.

Harrow, Inc.

Why Robinhood?

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. Show more

HROW Key Statistics

Analyst ratings

100%

People also own

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development.